Plasminogen activator inhibitor-1 (PAI-1) is the main regulator of the fibrinolytic system.
血浆纤溶酶原激活物抑制剂(PAI) - 1是纤溶系统的主要调控因子。
Conclusion Captopril enhances the endogenous fibrinolytic system in patients with AMI and UAP.
结论卡托普利增强冠心病患者内源性纤溶系统活性。
Objective To study the changes in fibrinolytic system after 8-week swimming training under different loads in rats.
目的通过对大鼠进行8周不同负荷的游泳训练，研究运动对大鼠纤溶系统的影响。
Objective To investigate effects of fibrinolytic system upon deep venous thrombosis, focused on PLG, t-PA and PAI-1.
目的以纤溶酶原、t - PA和PAI - 1为轴心，探讨纤溶系统对深静脉血栓形成(DVT)的影响。
CONCLUSIONS Ultraviolet irradiation may activate fibrinolytic system and solve the thrombus near vascular anastomosis.
结论紫外线照射可激活纤溶系统，溶解血管吻合口局部血栓。
Conclusion it was suggested that the abnormal activities of fibrinolytic system is associated with insulin resistance in CHD.
结论冠心病患者的纤溶系统活性异常与胰岛素抵抗有关。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in patients with acute cerebral infarction.
目的探讨东菱克栓酶治疗急性脑梗死对凝血与纤溶系统的影响及意义。
The activator protein for the fibrinolytic system has wide application prospects and favorable economic value and social benefits.
本发明具有广阔的应用前景，具有良好的经济价值和社会效益。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in the patients with acute cerebral infarction.
目的探讨急性脑梗塞患者用东菱克栓酶治疗对其凝血与纤溶系统的影响。
Conclusion in the early stage of cerebral infarction, the lower patients' fibrinolytic system activity was, the poorer prognosis was.
结论脑梗死患者病初纤溶活性越低，预后越差。
Conclusion Fibrinolytic system may play some role in the pathogenesis of BD, and seems to have close correlation with activity of the disease.
结论纤溶凝血系统可能在BD发病机制中起一定作用，并与疾病活动有密切相关性。
ObjectiveTo study the effect and safety of external therapeutic ultrasound (ETUS) on the normal human body blood coagulation and fibrinolytic system.
目的研究体外治疗性超声(etus)对正常人体凝血及纤溶系统的影响。
So the activity of fibrinolytic system can provide valuable information in the diagnosis, assessment of clinical therapy and prognostic prediction of ACS.
纤溶系统活性对ACS的诊断、临床治疗及预后预测的评估有重要价值。
Plasminogen activator inhibitor-1 (PAI-1) is one of the important components of the plasma fibrinolytic system and plays an key role in maintaining its stability.
纤溶酶原激活物抑制物1 (PAI - 1)是血浆纤维蛋白溶解系统的重要组成物之一，对维持血浆纤溶系统的稳定起重要作用。
The physiological background of the human fibrinolytic system is briefly introduced, and, on the basis of that, assay methods for the thrombolysis activity of nattokinase are set up.
简介人体纤维蛋白溶解系统的生理学背景，对以此为依据建立的纳豆激酶溶栓活性测定方法进行了概括总结。
Hyperfunction of coagulation system and hypofunction of fibrinolytic system were more significant in patients with RAS and CAD accompanying with hypertension than patients without RAS on CAD.
高血压病合并RAS患者，尤其是合并有冠心病时，凝血功能亢进而纤溶功能降低。
Hyperfunction of coagulation system and hypofunction of fibrinolytic system were more significant in patients with RAS and CAD accompanying with hypertension than patients without RAS on CAD.
高血压病合并RAS患者，尤其是合并有冠心病时，凝血功能亢进而纤溶功能降低。
应用推荐